Transcatheter aortic-valve replacement with a self-expanding prosthesis Academic Article uri icon

Overview

MeSH Major

  • Aortic Valve
  • Aortic Valve Stenosis
  • Bioprosthesis
  • Cardiac Catheterization
  • Heart Valve Prosthesis

abstract

  • In patients with severe aortic stenosis who are at increased surgical risk, TAVR with a self-expanding transcatheter aortic-valve bioprosthesis was associated with a significantly higher rate of survival at 1 year than surgical aortic-valve replacement. (Funded by Medtronic; U.S. CoreValve High Risk Study ClinicalTrials.gov number, NCT01240902.).

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1400590

PubMed ID

  • 24678937

Additional Document Info

start page

  • 1790

end page

  • 8

volume

  • 370

number

  • 19